GC Therapeutics

About:

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Website: https://www.gc-tx.com

Twitter/X: gctherapeutics

Top Investors: Alumni Ventures, Andreessen Horowitz, Global Brain Corporation, Pear VC, Cormorant Asset Management

Description:

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner. They have verified cells for several applications by dictating cell fates in a single step. They've also created SuperCells™ by customizing cells for certain conditions. Professor George Church's lab at Harvard Medical School is where GC Therapeutics' fundamental technology was developed, invented, and refined. They are a group of dedicated biologists and tissue engineers whose mission is to bring this ground-breaking method to patients.

Total Funding Amount:

$65.3M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)gc-tx.com

Founders:

Alex Ng, Cory Smith, Parastoo Khoshakhlagh

Number of Employees:

11-50

Last Funding Date:

2024-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai